| Ticker |
AXGN
|
| CIK | 0000805928 |
| SIC | 3845 |
| Sector | Manufacturing |
| Industry Category | Medical Equipment |
| Industry Group | Surgical, Medical, And Dental Instruments And Supplies |
| Address | 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615 |
| Website | axogeninc.com |
| Phone | (386) 462-6817 |
| CEO | Karen L. Zaderej |
| Employees | 450 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
What Makes Axogen (AXGN) an Investment Bet?TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned 3.70% (gross) and 3.45% (net) in the fourth quarter compared to a 1.22% return for the Russell 2000 Growth Index. In 2025, the strategy […] Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to KnowThis surgical solutions provider for nerve repair reported a notable insider sale amid a year of strong share price gains. This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue GrowthThis healthcare firm develops advanced surgical solutions for peripheral nerve repair, serving hospitals and specialists worldwide. Is Axogen (AXGN) Fairly Priced After Strong 72.7% One Year Share GainWondering if Axogen at around US$31.16 is offering fair value, or if you might be paying too much for recent excitement in the share price. The stock has been choppy in the short term, with a 1.9% decline over the last week and a 10.0% decline over the last month, yet it still sits on a small 0.5% gain year to date and a strong 72.7% return over the last year. These moves come against a backdrop of Axogen continuing to attract attention as a specialized medical equipment name, with investors... Do Options Traders Know Something About Axogen Stock We Don't?Investors need to pay close attention to AXGN stock based on the movements in the options market lately. |
